Chris Wertz

VP, Pharmaceutical Sciences

Dr. Wertz leads Nanocopoeia’s research and development efforts into novel pharmaceutical products.

Chris has more than 20 years of industry experience, spanning all stages of product development across a wide range of product forms and platforms.  Prior to joining Nanocopoeia, Chris was Director, Pharmaceutical Development at Upsher-Smith Laboratories, where he was responsible for formulation and process development in support of the company’s ANDA and NDA portfolios.  Chris also worked at Vertex and Elan Pharmaceuticals where he led their line extension and specialty formulation development.

Dr. Wertz has M.S. and Ph.D. degrees in Chemical Engineering from Lehigh University and a B.S. degree in Chemical Engineering from the University of Minnesota.